Similar screens aimed at identifying UBA1-dependent target proteins in affected cell populations in other neurodegenerative conditions (e.g., HD, ALS, PD) may therefore also serve to generate novel therapeutic targets and development strategies. This evidence concerns the gene UBA1 and amyotrophic lateral sclerosis.